(Q46059099)

19 December 2017

title

Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy (English)

1 reference

19 December 2017

0 references

1 reference

Antonio Barbato

1

1 reference

19 December 2017

Roberto Iacone

2

1 reference

19 December 2017

Giovanni Tarantino

3

1 reference

19 December 2017

Ornella Russo

4

1 reference

19 December 2017

Paolo Sorrentino

5

1 reference

19 December 2017

Sonia Avallone

6

1 reference

19 December 2017

Ferruccio Galletti

7

1 reference

19 December 2017

Eduardo Farinaro

8

1 reference

19 December 2017

Elisabetta Della Valle

9

1 reference

19 December 2017

Pasquale Strazzullo

10

1 reference

19 December 2017

Olivetti Heart Study Research Group

11

1 reference

19 December 2017

publication date

7 April 2009

1 reference

19 December 2017

Internal and emergency medicine

published in

1 reference

19 December 2017

volume

4

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

315-323

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s11739-009-0240-9

exact match

0 references

cites work

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-009-0240-9

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-009-0240-9

Hypertriglyceridemia and fatty liver: clinical diagnosis of fatty liver and lipoprotein profiles in hypertriglyceridemic patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-009-0240-9

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-009-0240-9

Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study

21 January 2018

1 reference

12 December 2020

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice

1 reference

12 December 2020

Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.

1 reference

12 December 2020

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

12 December 2020

Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke

1 reference

12 December 2020

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

1 reference

12 December 2020

Alcohol consumption and plasminogen activator inhibitor type 1: The national heart, lung, and blood Institute family heart study

1 reference

12 December 2020

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

12 December 2020

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

12 December 2020

Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients.

1 reference

12 December 2020

Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan.

1 reference

12 December 2020

Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men--role of the metabolic syndrome

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

12 December 2020

VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor

1 reference

12 December 2020

Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.

1 reference

12 December 2020

PAI-1 and atherothrombosis

1 reference

12 December 2020

Methods of estimation of visceral fat: advantages of ultrasonography.

1 reference

12 December 2020

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

1 reference

12 December 2020

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease

1 reference

12 December 2020

Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease.

1 reference

12 December 2020

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults

1 reference

12 December 2020

Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver

1 reference

12 December 2020

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

1 reference

12 December 2020

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

12 December 2020

Visceral fat as a determinant of fibrinolysis and hemostasis

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project.

1 reference

12 December 2020

Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects

1 reference

12 December 2020

Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome

1 reference

12 December 2020

Altered renal sodium handling in men with abdominal adiposity: a link to hypertension

1 reference

12 December 2020

Effects of VLDL and remnant particles on platelets

1 reference

12 December 2020

Adipose tissue and atherothrombosis

1 reference

12 December 2020

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

12 December 2020

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

1 reference

12 December 2020

Overweight/obesity, smoking, and heavy alcohol consumption are important determinants of plasma PAI-1 levels in healthy men.

1 reference

12 December 2020

Recent concepts in non-alcoholic fatty liver disease

1 reference

12 December 2020

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

1 reference

12 December 2020

Interobserver and intraobserver variability in the sonographic assessment of fatty liver

1 reference

12 December 2020

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020

10.1007/S11739-009-0240-9

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19350365

1 reference

19 December 2017